13F Portfolios

Saturn V Capital Management LP: IMMIX BIOPHARMA INC (IMMX): Quarterly 13F Position History

As of Q2 2026, Saturn V Capital Management LP reported 4,658,429 shares of IMMIX BIOPHARMA INC (IMMX), worth $48.0M and representing 6.9% of its 13F equity book. Quarter-over-quarter share count change: + 964,844 (+26.1%) . The position first appeared in Q4 2025 and has been disclosed across 3 13F-HR filings in Pactolio's tracked window.

Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 3 quarter s

Quarter Shares QoQ Share Change Share Change (%) Market Value Weight Implied Price
Q2 2026 4,658,429 +964,844 +26.1% $48.0M 6.9% $10.3
Q1 2026 3,693,585 +694,416 +23.2% $33.6M 6.1% $9.1
Q4 2025 2,999,169 $15.7M 2.9% $5.2

Methodology & FAQ

How This Position History Is Sourced

Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares, a quarter-end mark rather than the manager's cost basis. See the full methodology document for the normalization rules.

When did Saturn V Capital Management LP first disclose a IMMX position in 13F-HR filings?

Saturn V Capital Management LP first reported IMMIX BIOPHARMA INC (IMMX) on its 13F-HR filing for the period ending 2025-12-31 (Q4 2025). The position has appeared on 3 reported quarters within Pactolio's tracked window.

What was Saturn V Capital Management LP's most recent quarter-over-quarter share-count change in IMMX?

Between Q1 2026 and Q2 2026, Saturn V Capital Management LP added 964,844 shares of IMMX (+26.1%), bringing the total reported position to 4,658,429 shares at a market value of $48.0M.

Does the implied price-per-share represent Saturn V Capital Management LP's cost basis in IMMX?

No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.